Ribomic (TSE:4591) Accounts Payable & Accrued Expense : 円65.81 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Ribomic Accounts Payable & Accrued Expense?

Ribomic's quarterly accounts payable & accrued expense declined from Jun. 2023 (円119.99 Mil) to Sep. 2023 (円54.71 Mil) but then increased from Sep. 2023 (円54.71 Mil) to Dec. 2023 (円65.81 Mil).

Ribomic's annual accounts payable & accrued expense increased from Mar. 2021 (円82.89 Mil) to Mar. 2022 (円212.65 Mil) but then declined from Mar. 2022 (円212.65 Mil) to Mar. 2023 (円155.21 Mil).

Ribomic Accounts Payable & Accrued Expense Historical Data

The historical data trend for Ribomic's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ribomic Accounts Payable & Accrued Expense Chart

Ribomic Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

53.93

52.27

82.89

212.65

155.21

Ribomic Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															148.91	155.21	119.99	54.71	65.81

Ribomic Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Ribomic (TSE:4591) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ribomic Inc (TSE:4591) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071

Website

http://www.ribomic.com

Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.

Ribomic (TSE:4591) Headlines

No Headlines